![](/img/cover-not-exists.png)
Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])
Hänggi, Daniel, Etminan, Nima, Aldrich, Francois, Steiger, Hans Jakob, Mayer, Stephan A., Diringer, Michael N., Hoh, Brian L., Mocco, J, Faleck, Herbert J., Macdonald, R. LochVolume:
48
Language:
english
Journal:
Stroke
DOI:
10.1161/STROKEAHA.116.014250
Date:
January, 2017
File:
PDF, 1.20 MB
english, 2017